| 173 |
167: Activation, LXR |
54: Up Regulation, CD36 |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 174 |
167: Activation, LXR |
66: Activation, ChREBP |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 175 |
167: Activation, LXR |
116: Activation, FAS |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 176 |
167: Activation, LXR |
258: Activation, SCD-1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 177 |
167: Activation, LXR |
264: Activation, SREBP-1c |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 182 |
173: N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number |
321: N/A, Cyanosis occurs |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 215 |
195: Inhibition, NMDARs |
191: Neuronal dysfunction |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 188 |
178: Mitochondrial electron transport chain, disrupted |
40: Mitochondrial ATP production, decreased |
Nov 29, 2016 |
Dec 3, 2016 |
3 AOPs
|
| 190 |
179: Decrease, Fatty acid β-oxidation |
327: Accumulation, Fatty acid |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 196 |
183: Abnormal, Morphogenesis |
342: Increased, Lethality |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 198 |
350: Increase, Mortality |
328: Decrease, Fecundity |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 199 |
350: Increase, Mortality |
361: Decline, Population |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 228 |
201: Binding of antagonist, NMDA receptors |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 200 |
351: Increased Mortality |
361: Decline, Population |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 212 |
193: Decreased, Nitric Oxide |
166: Decreased, Long-term potentiation (LTP) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 214 |
195: Inhibition, NMDARs |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 136 |
119: N/A, Gap |
49: Reduction, Ca and HCO3 transport to shell gland |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 123 |
106: Reduction, Eggshell thickness |
253: N/A, Reproductive failure |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 126 |
111: Agonism, Estrogen receptor |
363: Altered, Reproductive behaviour |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 127 |
111: Agonism, Estrogen receptor |
364: Impaired development of, Reproductive organs |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 133 |
116: Activation, FAS |
89: Synthesis, De Novo Fatty Acid (FA) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 135 |
328: Decrease, Fecundity |
361: Decline, Population |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 146 |
134: Increase, Kupffer cell activation |
209: Peptide Oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 154 |
140: Decreased, HSD17B10 expression |
8: Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 158 |
142: Hyperplasia, Hyperplasia |
334: Promotion, Hepatocelluar carcinoma |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|